feasibility and efficacy of chemotherapy combined with zoledronic acid : phase I/II trial for adult T-cell leukemia/lymphoma (ZAAT study)
Phase 1
- Conditions
- Adult T-cell leukemia/lymphoma
- Registration Number
- JPRN-UMIN000007569
- Lead Sponsor
- Saga University, Faculty of Medicine, Devision of Hematology and Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
Not provided
Exclusion Criteria
a)History of glaucome b) Uncontrollable diabetes mellitus or administration of insulin c) Uncontrollable hypertension d) Poor cardiac function e) Active infection requiring systemic therapy f) acute hepatitis, chronic hepatitis, liver cirrhosis g) Synchronous or metachronous maliganacy h) Psychological problem i) active dental disease indicating invasive dental treatment j) Systemic steroid treatment k) History of adminisration of intravenous bisphophonate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method